Trial Profile
Exenatide in Extreme Pediatric Obesity.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2019
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2012 Results presented at the 2012 Annual Meeting of the North American Association for the Study of Obesity.
- 22 Sep 2012 Primary endpoint 'Body-mass-index' has been met.